Drug research company PPD' shares soar 14% in trading debut

  • 📰 MarketWatch
  • ⏱ Reading Time:
  • 7 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 6%
  • Publisher: 97%

United States News News

United States United States Latest News,United States United States Headlines

Shares of drug company PPD soar in post-IPO trading debut

PPD Inc. shares PPD, +13.78% soared 14% in their trading debut Thursday, after the drug research company's initial public offering priced at the high end of its $24 to $27 price range. The company sold 60 million shares to raise $1.62 billion. Sixteen banks underwrote the deal, led by Barclays, JPMorgan, Morgan Stanley and Goldman Sachs. Proceeds of the deal will be used to pay down debt and for general corporate purposes.

#div-gpt-ad-1569967089584-0 > div > iframe { width: 100% !important; min-width: 300px; max-width: 800px; }

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 3. in US

United States United States Latest News, United States United States Headlines